Details for New Drug Application (NDA): 009087
✉ Email this page to a colleague
NDA 009087 describes HYDERGINE, which is a drug marketed by Novartis and is included in four NDAs. Additional details are available on the HYDERGINE profile page.
The generic ingredient in HYDERGINE is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
The generic ingredient in HYDERGINE is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for 009087
| Tradename: | HYDERGINE |
| Applicant: | Novartis |
| Ingredient: | ergoloid mesylates |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009087
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 0.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
